Addition of Mycobacterium Cell Wall Fraction as Immunomodulator to Improve the Efficacy of Oil Emulsion-Inactivated Avian Influenza Vaccine in Broiler Chickens

Authors

  • Rakani Sara Agronomy and Veterinary Institute Hassan II, Avian Pathology Unit, Rabat, Morocco
  • Masic Aleksandar Ontario Veterinary College (OVC) University of Guelph, Pathobiology Department, Ontario, Canada
  • Bidoudan Yasmina Agronomy and Veterinary Institute Hassan II, Avian Pathology Unit, Rabat, Morocco
  • Hussein Mohamed International Sales and Marketing, Novavive, Canada
  • Frago Amine Agronomy and Veterinary Institute Hassan II, Avian Pathology Unit, Rabat, Morocco
  • Khantour Abderrazak Division of Pharmacy and Veterinary Inputs, ONSSA, Rabat, Morocco
  • Nassik Saâdia Agronomy and Veterinary Institute Hassan II, Avian Pathology Unit, Rabat, Morocco

DOI:

https://doi.org/10.12970/2310-0796.2021.09.04

Keywords:

Immunomodulation, Avian Influenza, vaccination, Mycobacterium Cell Wall fraction, Adjuvant

Abstract

Mycobacterial lipids have strong immunomodulatory effects which can be exploited for vaccine development. In this Study, we associated the injection of Mycobacterium Cell Wall Fraction (MCWF) with vaccination against Avian Influenza H9N2 by using a commercial inactivated oil emulsion vaccine in Broiler chicken and assessed the immune response. High levels of mucosal hemagglutinin inhibitory antibodies were detected in groups immunized with MCWF and AI vaccine, compared to group vaccinated with AI vaccine alone. MCWF induced a longer and an increased local protection in both respiratory and intestinal tracts. Serum levels of antibodies were not significantly different among groups. Cytokines of humoral and cell mediated immunity were also assessed. MCWF influences the balance Th1/Th2, by increasing Th2 cytokines that downregulate the cellular immune response and promote innate immune response, and inducing the Th1/Th2 network. Our results show that MCWF has a potential to be used as adjuvant in AI vaccines by inducing a robust, broad and long lasting protective immune responses in broiler chickens.

References

Suarez, L D. Influenza A Virus. Book Editor(s): David E. Swayne, Chapter 1, 04 March 2008. https://doi.org/10.1002/9780813818634.ch1

World Organization for Animal Health. OIE-Listed diseases 2019. World Organization for Animal Health; 2019. [Citation: 08 April 2019.] https://www.oie.int/en/animal-health-in-the-world/oie-listed-diseases-2019/.

EL Houadfi M, Fellahi S, Nassik S, Guérin JL, Ducatez MF. First outbreaks and phylogenetic analyses of avian influenza H9N2 viruses isolated from poultry flocks in Morocco. Virology journal, 2016; 13:140 pp. 1-7. https://doi.org/10.1186/s12985-016-0596-1

Spackman, E. A Brief Introduction to the Avian Influenza Virus. Methods in Molecular Biology, Vol. 436: Avian Influenza Virus. Totowa (NJ): 2008. Humana Press Inc. https://doi.org/10.1007/978-1-59745-279-3_1

Sims LD, Weaver J, Swayne DE. Epidemiology of Avian Influenza in Agricultural and Other Man-Made Systems. David E Swayne. 2016.Chapter 12. https://doi.org/10.1002/9781118924341.ch12

Abdel-Hafez M, Moemen A M. Evaluation of Some Immunostimulants on the Immune-response of Broiler Chickens Against Avian Influenza and Newcastle Diseases Vaccination. Zagazig Veterinary Journal, 2016. Vol. 44, pp. 273-281.

Swayne D. E, Kapczynski D. R. Vaccines, Vaccination, and Immunology for Avian Influenza Viruses in Poultry. Avian Influenz, 2008; s.l. : John Wiley & Sons, Inc.

Spickler, A. R. et Roth, J. A. Adjuvants in Veterinary Vaccines: Modes of Action and Adverse Effects.Veterinary Internal Medicine, 2003. Vol. 17, pp. 273-281.

Chedid L, Miescher P.A, Müller-Eberhard H.J. Immunostimulation. Springer seminars in immunopathology, 1980.Vol. 2, pp. 1-2. ISBN 978-3-642-67809-7.

Griebel P. Evaluation of the ability of Mycobacterium cell wall fraction (MCW) immunostimulant to alter blood leukocyte populations in newborn calves. 1999. Vaccine and Infectious Disease organizaton (VIDO).

Filion M C, Phillips N C. Therapeutic potential of mycobacterial cell wall-DNA complexes. Journal Expert Opinion on Investigational Drugs, Volume 10, 2001 - Issue 12, pp. 2157-2165.

Rogan D, Fumuso E, Rodriguez E, Wad J, Sánchez Bruni S.F. Use of a Mycobacterial Cell Wall Extract (MCWE) in susceptible mares to clear experimentally induced endometritis with Streptococcus zooepidemicus. Journal of Equine Veterinary Science; 2007. https://doi.org/10.1016/j.jevs.2007.01.010

Christoffersen M, Woodward E.M, Bojesen A.M , Petersen M.R , Squires E.L , Lehn-Jensen H, Troedsson M.H.T. Effect of immunomodulatory therapy on the endometrial inflammatory response to induced infectious endometritis in susceptible mares. Theriogenology, 2012. pp. 991–1004. https://doi.org/10.1016/j.theriogenology

Romanowski R, Culbert R, Alkemade S, Medellin-peña MJ, Bugarski D, Milovanovic A, Nesic S, Masic A. Mycobacterium cell wall fraction immunostimulant (AMPLIMUNE™) efficacy in the reduction of the severity of ETEC induced diarrhea 2017. in neonatal calves. Acta Veterinaria, Vol. 67, pp. 222-237. https://doi.org/10.1515/acve-2017-0019

Nosky B, Biwer J , Alkemade S, Prunic B, Milovanovic A, Maletic M, Masic A. Effect of a Non-Specific Immune Stimulant (Amplimune™) on the Health and Production of Light Feedlot Calves. 2017. Journal of Dairy Veterinary & Animal Research, Vol. 6. https://doi.org/10.15406/jdvar.2017.06.00179

Williams P, Losa R. The use of essential oils and their compounds in poultry nutrition. 2001.World Poultry, Vol. 17, pp. 14-15.

Hashemipour H, Kermanshahi H, Golian A, Veldkamp T. Effect of thymol and carvacrol feed supplementation on performance, antioxidant enzyme activities, fatty acid composition, digestive enzyme activities, and immune response in broiler chickens 2003. Poultry science, pp. 2059-2069.

Ghalamkari G, Toghyani M, Tavalaeian E, Landy N, Ghalamkari Z, Radnezhad H. Efficiency of different levels of Satureja hortensis L. (Savory) in comparison with an antibiotic growth promoter on performance, carcass traits, immune responses and serum biochemical parameters in broiler chickens 2011. African Journal of Biotechnology,Vol. 10(61), pp. 13318-13323, 10 October, 2011. https://doi.org/10.5897/AJB11.911

Lamb R.A, Krug R.M. Orthomyxoviridae:the viruses and their replication. 1996. Fields Virology, pp. 1353–1395, In D. M. Knipe, P. M. Howley, & B. N. Fields (Eds.), Fields Virology Philadelphia: Lippincott-Raven Press.

Kaiser P, Kaspers B, Schat K.A. Avian Immunology. 2nd Edition. 2014; Hardcover ISBN: 9780123969651 eBook ISBN: 9780123972729; 2014.

Singh SM, Alkie TN, Nagy É, Kulkarni RR, Hodgins DC, Sharif S. Delivery of an inactivated avian influenza virus vaccine adjuvanted with poly (D,L-lactic-co-glycolic acid) encapsulated CpG ODN induces protective immune responses in chickens 2016. Vaccine, 34(40): 4807-13. https://doi.org/10.1016/j.vaccine.2016.08.009

Renegar K.B, Small PAJ. Passive transfer of local immunity to influenza virus infection by IgA antibody 1991. Journal of Immunology, Vol. 146, pp. 1972–1978.

Ramsay AJ, Husband AJ, Ramshaw IA, Bao S, Matthaei KI, Koehler G, Kopf M. The role of interleukin-6 in mucosal IgA antibody responses in vivo 1994. Science, Apr 22;264(5158):561-3.

Cox JC, Coulter AR. Adjuvants—a classification and review of their modes of action 1997. Vaccine, Volume 15, Issue 3, Pages 248-256.

Wigley P, Kaiser PK. Avian Cytokines in Health and Disease 2003. Brazilian Journal of Poultry Science, vol.5 no.1. https://doi.org/10.1590/S1516-635X2003000100001

Downloads

Published

2021-06-01

Issue

Section

Articles